JPH0859576A - Method for producing optically active aminoketone and aminoalcohol - Google Patents
Method for producing optically active aminoketone and aminoalcoholInfo
- Publication number
- JPH0859576A JPH0859576A JP6215255A JP21525594A JPH0859576A JP H0859576 A JPH0859576 A JP H0859576A JP 6215255 A JP6215255 A JP 6215255A JP 21525594 A JP21525594 A JP 21525594A JP H0859576 A JPH0859576 A JP H0859576A
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- optically active
- represented
- amino acid
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims description 22
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 title claims description 6
- 239000007818 Grignard reagent Substances 0.000 claims abstract description 25
- 150000004795 grignard reagents Chemical class 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 24
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims abstract description 19
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- 125000003118 aryl group Chemical group 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- -1 t-butyloxycarbonyl group Chemical group 0.000 claims description 22
- 239000003638 chemical reducing agent Substances 0.000 claims description 15
- 150000001414 amino alcohols Chemical class 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 2
- 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 claims description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- GIZSHQYTTBQKOQ-UHFFFAOYSA-N threo-Syringoylglycerol Chemical compound COC1=CC(C(O)C(O)CO)=CC(OC)=C1O GIZSHQYTTBQKOQ-UHFFFAOYSA-N 0.000 claims description 2
- 150000004292 cyclic ethers Chemical class 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract description 19
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 abstract description 5
- GNIDSOFZAKMQAO-VIFPVBQESA-N (2s)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 GNIDSOFZAKMQAO-VIFPVBQESA-N 0.000 abstract description 4
- 239000003905 agrochemical Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000000543 intermediate Substances 0.000 abstract description 4
- 230000003287 optical effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- WPOFMMJJCPZPAO-INIZCTEOSA-N benzyl n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]carbamate Chemical compound C([C@@H](CO)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 WPOFMMJJCPZPAO-INIZCTEOSA-N 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 239000007810 chemical reaction solvent Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 229940035437 1,3-propanediol Drugs 0.000 description 2
- ICKMPMAGRYUKNA-VYRBHSGPSA-N C1=CC=C(C=C1)COC(=O)N[C@@H](CO)C(C2=CC=CC=C2)O Chemical compound C1=CC=C(C=C1)COC(=O)N[C@@H](CO)C(C2=CC=CC=C2)O ICKMPMAGRYUKNA-VYRBHSGPSA-N 0.000 description 2
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- LZFCBBSYZJPPIV-UHFFFAOYSA-M magnesium;hexane;bromide Chemical compound [Mg+2].[Br-].CCCCC[CH2-] LZFCBBSYZJPPIV-UHFFFAOYSA-M 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- QCCDLTOVEPVEJK-UHFFFAOYSA-N phenylacetone Chemical compound CC(=O)CC1=CC=CC=C1 QCCDLTOVEPVEJK-UHFFFAOYSA-N 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- GNIDSOFZAKMQAO-SECBINFHSA-N (2r)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound OC[C@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 GNIDSOFZAKMQAO-SECBINFHSA-N 0.000 description 1
- MCRMUCXATQAAMN-HNNXBMFYSA-N (2s)-3-(4-hydroxyphenyl)-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=C(O)C=C1 MCRMUCXATQAAMN-HNNXBMFYSA-N 0.000 description 1
- FHOAKXBXYSJBGX-YFKPBYRVSA-N (2s)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CO)C(O)=O FHOAKXBXYSJBGX-YFKPBYRVSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- GPWXNTVVDHHGQF-UHFFFAOYSA-N C(=O)=NC(CCO)(O)C1=CC=CC=C1 Chemical compound C(=O)=NC(CCO)(O)C1=CC=CC=C1 GPWXNTVVDHHGQF-UHFFFAOYSA-N 0.000 description 1
- VWURURXGONOSBG-NRFANRHFSA-N C(C1=CC=CC=C1)OC(=O)N[C@H](C(=O)C1=CC=CC=C1)CC1=CC=C(C=C1)O Chemical compound C(C1=CC=CC=C1)OC(=O)N[C@H](C(=O)C1=CC=CC=C1)CC1=CC=C(C=C1)O VWURURXGONOSBG-NRFANRHFSA-N 0.000 description 1
- HHYWNXIHZBOHEI-OAHLLOKOSA-N C(C1=CC=CC=C1)OC(=O)N[C@H](CO)C(CCCCCC)=O Chemical compound C(C1=CC=CC=C1)OC(=O)N[C@H](CO)C(CCCCCC)=O HHYWNXIHZBOHEI-OAHLLOKOSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000080284 Lectrides Species 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- ICKMPMAGRYUKNA-UHFFFAOYSA-N benzyl N-(1,3-dihydroxy-1-phenylpropan-2-yl)carbamate Chemical compound C=1C=CC=CC=1C(O)C(CO)NC(=O)OCC1=CC=CC=C1 ICKMPMAGRYUKNA-UHFFFAOYSA-N 0.000 description 1
- ICKMPMAGRYUKNA-HOTGVXAUSA-N benzyl n-[(1s,2s)-1,3-dihydroxy-1-phenylpropan-2-yl]carbamate Chemical compound N([C@@H](CO)[C@@H](O)C=1C=CC=CC=1)C(=O)OCC1=CC=CC=C1 ICKMPMAGRYUKNA-HOTGVXAUSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical class B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- VEWFZHAHZPVQES-UHFFFAOYSA-N boron;n,n-diethylethanamine Chemical compound [B].CCN(CC)CC VEWFZHAHZPVQES-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- DSNYFFJTZPIKFZ-UHFFFAOYSA-N propoxybenzene Chemical group CCCOC1=CC=CC=C1 DSNYFFJTZPIKFZ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000011916 stereoselective reduction Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、医薬、農薬等の合成中
間体としてあるいは光学分割剤として有用な化合物であ
る光学活性アミノケトン及び光学活性アミノアルコール
の新規な合成法に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel method for synthesizing optically active aminoketones and optically active aminoalcohols, which are compounds useful as synthetic intermediates for drugs, agricultural chemicals, etc. or as optical resolving agents.
【0002】[0002]
【従来の技術】N−保護−α−アミノ酸を出発原料とし
たN−保護−α−アミノケトン類の合成法としては、ア
ミノ酸のカルボキシル基を酸塩化物とした後ベンゼンと
フリーデル−クラフツ反応させる方法(J.Am.Chem.So
c.、103、6157(1981))、アミノ酸のカルボキシル基をア
ルキルリチウム試薬で処理しリチウム塩とした後、グリ
ニャール試薬と反応させる方法等が知られている(J.Or
g.Chem.,54、1866(1989))。また、α−アミノアルコー
ルの製造法としては、α−アミノ酸またはそのエステル
に特定のグリニヤール反応剤を反応させる方法(特開昭
50ー29535、特開昭56ー65848)が知られている。2. Description of the Related Art As a method for synthesizing N-protected-α-aminoketones starting from N-protected-α-amino acid, the carboxyl group of the amino acid is converted to acid chloride and then reacted with benzene and Friedel-Crafts reaction. Method (J.Am.Chem.So
c. , 103 , 6157 (1981)), a method in which a carboxyl group of an amino acid is treated with an alkyllithium reagent to form a lithium salt and then reacted with a Grignard reagent (J. Or.
g. Chem., 54 , 1866 (1989)). Further, as a method for producing an α-amino alcohol, a method of reacting an α-amino acid or an ester thereof with a specific Grignard reaction agent (Japanese Patent Laid-Open No. S60-12065)
50-29535 and JP-A-56-65848) are known.
【0003】更に、N−保護−β−アミノアルコール類
の合成法としては、アミノケトン類を還元する方法
(J.Org.Chem.、54、1866(1989))、N−保護−アミノ酸
エステルを水素化ジイソブチルアルミニウム、続いてグ
リニャール試薬で処理する方法 (J.Org.Chem.,57、5469
(1992))N−保護−アミノアルデヒドやN−保護−アミ
ノ酸の酸塩化物にグリニャール試薬を反応させる方法等
が知られている。Further, as a synthetic method of N-protected-β-amino alcohols, a method of reducing amino ketones
(J. Org. Chem. , 54 , 1866 (1989)), a method of treating an N-protected-amino acid ester with diisobutylaluminum hydride followed by a Grignard reagent (J. Org. Chem., 57 , 5469).
(1992)) A method of reacting an acid chloride of N-protected-aminoaldehyde or N-protected-amino acid with a Grignard reagent is known.
【0004】[0004]
【発明が解決しようとする課題】アミノケトン誘導体を
得る場合、フリーデル−クラフツ反応によるアシル化で
は保護基、アミノ酸側鎖の種類、被アシル化体の構造に
制約が多く実用的ではない。またアルキルリチウムを用
いる方法は反応を低温で、例えば−78℃で行わなけれ
ばならない上、2段階反応であるなど操作が煩雑であり
かつ保護基や側鎖官能基に制約が多い。When an aminoketone derivative is obtained, acylation by the Friedel-Crafts reaction is not practical because there are many restrictions on the protecting group, the type of amino acid side chain, and the structure of the product to be acylated. Further, the method using alkyllithium requires complicated reactions such as reaction at a low temperature, for example, -78 ° C, and is a two-step reaction, and there are many restrictions on protecting groups and side chain functional groups.
【0005】また、アミノアルコール誘導体を得る場
合、水素化ジイソブチルアルミニウムとグリニャール試
薬を用いる方法では、エリトロ体とトレオ体のジアステ
レオマーのうち一方しか得られず、アミノアルデヒドや
酸塩化物を経由する方法ではそれらがラセミ化を起こし
たり不安定であったりするなどの問題があった。Further, in the case of obtaining an amino alcohol derivative, in the method using diisobutylaluminum hydride and a Grignard reagent, only one of the diastereomers of the erythro form and the threo form can be obtained, and the amino aldehyde or acid chloride is passed through. The methods had problems such as racemization and instability.
【0006】[0006]
【課題を解決するための手段】本発明者らは、前記一般
式(3)及び(4)の構造を持つ化合物の、より簡便か
つ一般性のある製造法を開発すべく研究を重ねた結果、
以下の構成によりその課題を達成する事に成功した。本
発明によれば、α−アミノ酸誘導体を直接、大過剰のグ
リニャール試薬と反応させることにより、温和な条件で
一段階で目的とする光学活性アミノケトンを得ることが
でき、さらに還元条件を選択することにより、該アミノ
ケトンから光学活性アミノアルコールを立体選択的に得
ることができる。Means for Solving the Problems As a result of repeated studies by the present inventors, a more convenient and general method for producing compounds having the structures of the above-mentioned general formulas (3) and (4) was developed. ,
We succeeded in achieving that task with the following configuration. According to the present invention, by directly reacting an α-amino acid derivative with a large excess of Grignard reagent, the desired optically active aminoketone can be obtained in one step under mild conditions, and further reducing conditions can be selected. Thus, an optically active amino alcohol can be stereoselectively obtained from the aminoketone.
【0007】すなわち、この発明は、一般式(1) R1−NH−C*H(R2)−COOH ・・・・(1) (式中、R1はアルキル基またはアミノ保護基を示し、
R2は置換基を有していてもよい炭素数1から8のアル
キル、アリール、アラルキル基を示し、また、R1とR2
は連結して−(CH2)3−又は−CH2−CH(OH)
−CH2−を示す。C*は不斉炭素原子を示す。)で示さ
れるα−アミノ酸誘導体に、一般式(2) R3MgX ・・・・(2) (式中、Xはハロゲン原子であり、R3は炭素数6から
20の置換基を有していても良い炭化水素基である。)
で示されるグリニヤール試薬を、該α−アミノ酸誘導体
に対し少なくとも5モル使用し、還流温度以下で反応さ
せることよりなる一般式(3) R1−NH−C*H(R2)−COR3 ・・・・(3) (式中、R1、R2、R3及びC*は前記と同義である。)
で示される光学活性アミノケトンの製造方法及び得られ
た光学活性アミノケトンを還元するか、一般式(1)と
(2)を反応させる際に予め還元剤を存在させることよ
りなる一般式(4) R1−NH−C*H(R2)−C*H(OH)R3 ・・・・(4) (式中、R1、R2、R3及びC*は前記と同義である。)
で示される光学活性アミノアルコールの製造方法を要旨
とするものである。That is, the present invention provides a compound represented by the general formula (1) R 1 —NH—C * H (R 2 ) —COOH (1) (wherein R 1 represents an alkyl group or an amino-protecting group). ,
R 2 represents an optionally substituted alkyl, aryl or aralkyl group having 1 to 8 carbon atoms, and R 1 and R 2
They are linked - (CH 2) 3 - or -CH 2 -CH (OH)
-CH 2 - shows the. C * represents an asymmetric carbon atom. ) In the α-amino acid derivative represented by the general formula (2) R 3 MgX ··· (2) (In the formula, X is a halogen atom, and R 3 has a substituent having 6 to 20 carbon atoms. It is a hydrocarbon group which may be present.)
The compound of the general formula (3) R 1 —NH—C * H (R 2 ) —COR 3 ·, which comprises reacting at least 5 mol of the Grignard reagent represented by (3) (In the formula, R 1 , R 2 , R 3 and C * are as defined above.)
The method for producing an optically active aminoketone represented by the formula and a compound represented by the general formula (4) R, which comprises reducing the obtained optically active aminoketone or presenting a reducing agent in advance when reacting the general formulas (1) and (2). 1 -NH-C * H (R 2) -C * H (OH) R 3 ···· (4) ( wherein, R 1, R 2, R 3 and C * are as defined above.)
The gist is the method for producing an optically active amino alcohol represented by.
【0008】以下、本発明につき詳細に説明する。本発
明の一般式(1)のα−アミノ酸誘導体の原料として使
用されるアミノ酸は、天然物、合成品を問わず、また、
L−体、D−体或いはラセミ体のいずれでも用いられ
る。一般式(1)中の置換基R1のアルキル基として
は、炭素数1から8のアルキル基であり、具体的には例
えば、メチル、エチル、プロピル、イソプロピル、n−
ブチル、iーブチル、t-ブチル等の直鎖、または分岐鎖
状のアルキル基、シクロヘキシル等のシクロアルキル
基、ベンジル等のアラルキル基、フェニル等のアリール
基が挙げられる。また、アミノ保護基としては、ペプチ
ド合成に使用されているものであり、例えば、ベンジル
オキシカルボニル基、t−ブチルオキシカルボニル基、
ベンゼンスルホニル基、フルオレニルメチルオキシカル
ボニル基等が挙げられるが、さらにはグリニャール試薬
との反応性が低ければそれ以外の基であっても良い。The present invention will be described in detail below. The amino acid used as a raw material of the α-amino acid derivative of the general formula (1) of the present invention may be a natural product or a synthetic product,
The L-form, the D-form or the racemic form can be used. The alkyl group as the substituent R 1 in the general formula (1) is an alkyl group having 1 to 8 carbon atoms, and specific examples thereof include methyl, ethyl, propyl, isopropyl and n-.
Examples thereof include linear or branched alkyl groups such as butyl, i-butyl, t-butyl, cycloalkyl groups such as cyclohexyl, aralkyl groups such as benzyl, and aryl groups such as phenyl. Further, the amino protecting group is one used in peptide synthesis, and examples thereof include a benzyloxycarbonyl group, a t-butyloxycarbonyl group,
Examples thereof include a benzenesulfonyl group and a fluorenylmethyloxycarbonyl group, but other groups may be used as long as the reactivity with the Grignard reagent is low.
【0009】一般式(1)中の置換基R2は、炭素数1
〜8のアルキル、アリール、アラルキル基であり、これ
らは置換基を有していても良い。具体的にはこれらは、
アミノ酸の側鎖であり、メチル(−CH3)、エチル
(−C2H5)、n−プロピル(−C3H7)、i−プロピ
ル(−CH(CH3)2)、n−ブチル(−C4H9)、i
−ブチル(−CH2−CH(CH3)2)、1ーメチルプ
ロピル(−CH(CH3)−CH2CH3)、ベンジル
(−CH2−C6H5)、シクロヘキシル(−C6H11)、
シクロヘキシルメチル(−CH2−C6H11)、ヒドロキ
シメチル(−CH2OH)、2−ヒドロキシエチル(−
CH2CH2OH)、1ーヒドロキシエチル(−CH(O
H)CH3)、4−ヒドロキシベンジル(−CH2−C6
H4−OH)、3、4−ジヒドロキシベンジル(−CH2
−C6H4−(OH)2)、メルカプトメチル(−CH2S
H)、メルカプトエチル(−CH2CH2SH)、2−メ
チルチオエチル(−CH2CH2SCH3)、カルボキシ
メチル(−CH2COOH)、アミノカルボニルメチル
(−CH2CONH2)、カルボキシエチル(−CH2C
H2COOH)、アミノカルボニルエチル(−CH2CH
2CONH2)、4−アミノブチル(−(CH2)4N
H2)、4−イミダゾリルメチル(−CH2−C3H
3N2)、3−インドリルメチル(−CH2−C8H
6N)、3−アミノプロピル(−CH2CH2CH2N
H2)基、さらには−(CH2)3−NH−C(NH)−
NH2、−(CH2)3−NH−CO−NH2等である。ア
ミノ酸がアスパラギン酸、グルタミン酸等のように側鎖
にカルボキシル基を有する場合は、反応に先だってオル
トエステル等に保護されたもの、また、リジン等のよう
に側鎖にアミノ基を有する場合は、前述のアミノ保護基
により保護されたものも包含される。また、R1とR2が
連結して−(CH2)3−又は−CH2−CH(OH)−
CH2−結合を示すのは、プロリン又はヒドロキシプロ
リンの場合である。The substituent R 2 in the general formula (1) has 1 carbon atom.
~ 8 alkyl, aryl, and aralkyl groups, which may have a substituent. Specifically, these are
Is the side chain of an amino acid, methyl (-CH 3), ethyl (-C 2 H 5), n- propyl (-C 3 H 7), i- propyl (-CH (CH 3) 2) , n- butyl (-C 4 H 9), i
- butyl (-CH 2 -CH (CH 3) 2), 1 -methylstyrene propyl (-CH (CH 3) -CH 2 CH 3), benzyl (-CH 2 -C 6 H 5) , cyclohexyl (-C 6 H 11 ),
Cyclohexylmethyl (-CH 2 -C 6 H 11) , hydroxymethyl (-CH 2 OH), 2- hydroxyethyl (-
CH 2 CH 2 OH), 1-hydroxyethyl (-CH (O
H) CH 3), 4- hydroxybenzyl (-CH 2 -C 6
H 4 -OH), 3,4- dihydroxy-benzyl (-CH 2
-C 6 H 4 - (OH) 2), mercaptomethyl (-CH 2 S
H), mercaptoethyl (-CH 2 CH 2 SH), 2- methylthioethyl (-CH 2 CH 2 SCH 3) , carboxymethyl (-CH 2 COOH), aminocarbonyl methyl (-CH 2 CONH 2), carboxyethyl (-CH 2 C
H 2 COOH), aminocarbonyl ethyl (-CH 2 CH
2 CONH 2), 4- aminobutyl (- (CH 2) 4 N
H 2), 4-imidazolylmethyl (-CH 2 -C 3 H
3 N 2 ), 3-indolylmethyl (-CH 2 -C 8 H
6 N), 3-aminopropyl (-CH 2 CH 2 CH 2 N
H 2) group, more - (CH 2) 3 -NH- C (NH) -
NH 2, - (CH 2) a 3 -NH-CO-NH 2 and the like. When the amino acid has a carboxyl group in the side chain such as aspartic acid and glutamic acid, those protected with an orthoester prior to the reaction, or when it has an amino group in the side chain such as lysine, And those protected by the amino-protecting group of. Further, R 1 and R 2 are linked to each other to form — (CH 2 ) 3 — or —CH 2 —CH (OH) —.
CH 2 - exhibit binding is the case of proline or hydroxyproline.
【0010】一般式(2)のグリニヤール試薬のR3と
しては、n−ヘキシル、シクロヘキシル、n−オクチル
等の炭素数6〜20のアルキル基;炭素数6〜20のア
ルケニル基;フェニル、メチルフェニル、メトキシフェ
ニル、プロポキシフェニル等の置換基を有し得るアリー
ル基;メトキシフェニル、メチルカルボニルフェニル、
3,4−ジメトキシフェニル、2,4−ジメトキシフェ
ニル、−NHZ(Zはアミノ保護基)基を有するフェニ
ル基等のような官能基がグリニャール試薬に対して不活
性な保護基で保護された置換基が例示される。また、X
で示されるハロゲン原子としては、塩素、臭素等が挙げ
られる。具体的には、n−ヘキシルマグネシウムブロミ
ド、フェニルマグネシウムブロミド等が挙げられる。本
発明において、グリニヤール試薬は、基質のα−アミノ
酸誘導体に対し、少なくとも5倍モル、好ましくは8倍
モルから10倍モル使用することが必要である。As R 3 of the Grignard reagent of the general formula (2), an alkyl group having 6 to 20 carbon atoms such as n-hexyl, cyclohexyl and n-octyl; an alkenyl group having 6 to 20 carbon atoms; phenyl, methylphenyl , An aryl group which may have a substituent such as methoxyphenyl and propoxyphenyl; methoxyphenyl, methylcarbonylphenyl,
Substitution in which a functional group such as a phenyl group having a 3,4-dimethoxyphenyl, 2,4-dimethoxyphenyl, -NHZ (Z is an amino-protecting group) group is protected by a protecting group which is inactive to the Grignard reagent. Groups are exemplified. Also, X
Examples of the halogen atom represented by include chlorine, bromine and the like. Specific examples include n-hexyl magnesium bromide and phenyl magnesium bromide. In the present invention, it is necessary to use the Grignard reagent in an amount of at least 5 times, preferably 8 times to 10 times the molar amount of the substrate α-amino acid derivative.
【0011】本反応は、通常溶液中で行われるが、使用
される溶媒としては、反応に不活性であれば特に制限は
無く、通常、テトラヒドロフラン、ジエチルエーテル、
ジオキサン、ジグライム、等のエーテル類が使用され
る。これらのうち基質の溶解性の点からは、テトラヒド
ロフランがより好ましい。反応温度は、氷零下では反応
の進行が遅く実用的ではなく、他方高温に過ぎると副反
応が生起する場合があるので、通常0℃から還流温度以
下、好ましくは15℃〜50℃程度であり、特にチロシ
ンのように基質の溶解性が劣るときは、適宜加温するの
が好ましい。反応時間は、適用する反応条件によっても
異なるが、少なくとも30分、通常1〜20時間であ
る。本発明において、基質のα−アミノ酸誘導体とグリ
ニヤール試薬の添加順序は特に制限されず、α−アミノ
酸誘導体にグリニヤール試薬を添加しても、その逆に添
加しても良い。This reaction is usually carried out in a solution, but the solvent used is not particularly limited as long as it is inert to the reaction, and usually tetrahydrofuran, diethyl ether,
Ethers such as dioxane, diglyme, etc. are used. Of these, tetrahydrofuran is more preferable from the viewpoint of solubility of the substrate. The reaction temperature is usually 0 ° C. to the reflux temperature or lower, preferably about 15 ° C. to 50 ° C., because the reaction progresses slowly under ice-free conditions and is not practical, and on the other hand, when it is too high, side reactions may occur. In particular, when the substrate has poor solubility such as tyrosine, it is preferable to appropriately heat. The reaction time varies depending on the reaction conditions applied, but is at least 30 minutes, usually 1 to 20 hours. In the present invention, the order of adding the α-amino acid derivative of the substrate and the Grignard reagent is not particularly limited, and the Grignard reagent may be added to the α-amino acid derivative or vice versa.
【0012】反応終了後、生成した光学活性のアミノケ
トン類を得る場合は、反応液中の過剰のグリニヤール試
薬を希塩酸、希硫酸、酢酸またはクエン酸等の水溶液で
分解処理したのち、分液等の通常行われている方法で粗
生成物を得、必要に応じて再結晶法、カラムクロマトグ
ラフィー等により精製される。本発明において、光学活
性アミノアルコール類を製造する場合は、上記のように
して得られた光学活性アミノケトン類を還元剤で還元す
る。その際、アミノケトン類は、グリニヤール試薬との
反応生成液から単離されてもされなくても良い。When the optically active aminoketones formed are obtained after the reaction, the excess Grignard reagent in the reaction solution is decomposed with an aqueous solution of dilute hydrochloric acid, dilute sulfuric acid, acetic acid or citric acid, and then separated. A crude product is obtained by a commonly used method and, if necessary, purified by a recrystallization method, column chromatography or the like. In the present invention, when producing optically active amino alcohols, the optically active amino ketones obtained as described above are reduced with a reducing agent. At that time, the aminoketones may or may not be isolated from the reaction product solution with the Grignard reagent.
【0013】還元剤としては各種金属水素錯化合物、例
えば、水素化ホウ素ナトリウム、水素化ホウ素リチウ
ム、ジイソブチルアルミニウムハイドライド、水素化ア
ルミニウムリチウム、またはK−セレクトリド(K−Se
lectride)、L−セレクトリド(L−Selectride)等が
挙げられ、また、ジボラン、トリエチルアミンーボラン
等のボラン類も使用することが出来る。還元剤の使用量
は、還元剤の種類、被還元物質により異なるが、通常被
還元物質にたいし当量から2倍モル使用される。還元反
応は、−78℃〜50℃の間で適宜選択される。また、
α−アミノ酸誘導体とグリニヤール試薬との反応を還元
剤の存在下行うことにより、α−アミノ酸誘導体から光
学活性アミノアルコールを一段で製造することができる
が、その場合はグリニヤール試薬の添加後に還元剤を加
えるのが好ましい。As the reducing agent, various metal-hydrogen complex compounds such as sodium borohydride, lithium borohydride, diisobutylaluminum hydride, lithium aluminum hydride, or K-selectride (K-Se) can be used.
lectride), L-Selectride, and the like, and boranes such as diborane and triethylamine-borane can also be used. Although the amount of the reducing agent used varies depending on the type of the reducing agent and the substance to be reduced, it is usually used in an amount equivalent to twice the molar amount of the substance to be reduced. The reduction reaction is appropriately selected between -78 ° C and 50 ° C. Also,
By carrying out the reaction between the α-amino acid derivative and the Grignard reagent in the presence of a reducing agent, an optically active amino alcohol can be produced from the α-amino acid derivative in a single step. In that case, the reducing agent is added after the addition of the Grignard reagent. It is preferable to add.
【0014】本発明においては、使用する還元剤の種
類、量、溶媒の種類、反応温度等の反応条件により得ら
れる光学活性アミノアルコールのジアステレオマー混合
物の比率が変わるので、これらの条件を適宜組合わせる
ことにより立体選択的な還元が可能であり、エリトロ
体、トレオ体のいずれかを高選択的に得ることができ
る。例えば、還元剤としてK−セレクトリドあるいはジ
イソブチルアルミニウムハイドライドを用いた場合、テ
トラヒドロフランのようなエーテル系溶媒では互いにジ
アステレオマーの関係にある異性体の一方が優先的に生
成する。In the present invention, the ratio of the diastereomer mixture of the optically active amino alcohol obtained varies depending on the reaction conditions such as the type and amount of reducing agent used, the type of solvent and the reaction temperature. By combining them, stereoselective reduction is possible, and either an erythro body or a threo body can be obtained with high selectivity. For example, when K-selectride or diisobutylaluminum hydride is used as the reducing agent, one of the isomers having a diastereomeric relationship with each other is preferentially produced in an ether solvent such as tetrahydrofuran.
【0015】反応終了後、生成した光学活性のアミノア
ルコール類の単離は、まず反応液中の還元剤及び場合に
より存在する過剰のグリニヤール試薬を水または希塩
酸、希硫酸、酢酸またはクエン酸等の水溶液で分解処理
する。ついで、得られた生成液から、抽出、分液、蒸留
等の通常行われている方法で粗生成物を得、必要に応じ
て再結晶法、カラムクロマトグラフィー等により精製さ
れる。生成した光学活性アミノアルコールがジアステレ
オマー混合物の場合にはそのモル比をNMR、HPLC
等により決定することができ、さらに再結晶法またはク
ロマトグラフィー等によりそれぞれのジアステレオマー
に分離することができる。After completion of the reaction, the optically active amino alcohols formed are isolated by first removing the reducing agent and the excess Grignard reagent present in the reaction solution from water or diluted hydrochloric acid, diluted sulfuric acid, acetic acid or citric acid. Decompose with aqueous solution. Then, a crude product is obtained from the obtained product solution by a commonly used method such as extraction, liquid separation, distillation or the like, and if necessary, purified by a recrystallization method, column chromatography or the like. When the produced optically active amino alcohol is a diastereomer mixture, its molar ratio is determined by NMR, HPLC.
Etc., and can be separated into each diastereomer by a recrystallization method, chromatography or the like.
【0016】上述のように、本発明方法によれば、穏和
な条件でα−アミノ酸誘導体に過剰量のグリニヤール試
薬を直接作用させることにより、簡単な工程で目的とす
る光学活性アミノケトンをで生成することができ、更
に、このアミノケトンを還元して光学活性アミノアルコ
ールを生成する際、還元剤の種類、溶媒の種類、反応条
件等を適宜選択することにより立体選択的にアミノアル
コールを取得することができる。このようにして得られ
た光学活性アミノケトン及び光学活性アミノアルコール
は、医薬、農薬の合成中間体として或いは光学分割剤と
して有用である。As described above, according to the method of the present invention, the desired optically active aminoketone can be produced in a simple process by causing an excess amount of the Grignard reagent to directly act on the α-amino acid derivative under mild conditions. Further, when the aminoketone is reduced to produce an optically active aminoalcohol, the aminoalcohol can be stereoselectively obtained by appropriately selecting the type of reducing agent, the type of solvent, the reaction conditions and the like. it can. The thus obtained optically active aminoketone and optically active amino alcohol are useful as synthetic intermediates for medicines and agricultural chemicals, or as optical resolving agents.
【0017】[0017]
【実施例】以下、本発明を実施例により更に詳細に説明
するが、本発明はこれら実施例に限定されるものではな
い。EXAMPLES The present invention will now be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0018】[0018]
【実施例1】フェニルマグネシウムブロミドのテトラヒ
ドロフラン溶液(1M,16ml)にアルゴン雰囲気
中、氷冷下にて2mlのテトラヒドロフランに溶解した
N−ベンジルオキシカルボニル−L−セリン(479m
g,2.0ミリモル)を2分間で滴下した。室温にて一
晩攪伴した後、1Mの塩酸を含む氷水中に投入し、酢酸
エチルにて抽出した。有機層を水、5%炭酸水素ナトリ
ウム水溶液、水、飽和食塩水にて洗浄後、無水硫酸ナト
リウム上で乾燥し、溶媒を減圧留去して(2S)−2−
ベンジルオキシカルボニルアミノ−3−ヒドロキシ−1
−フェニルプロパノンを淡黄色の結晶として548mg
得た(収率91.5%)。酢酸エチル−ヘキサンより再
結晶したサンプルは白色針状でm.p.109℃、
[α]20 D−5.7゜(cl,CH3OH)であった。1
H−NMRスペクトルにより(2S)−2−ベンジルオ
キシカルボニルアミノ−3−ヒドロキシ−1−フェニル
プロパノンであることを確認した。Example 1 N-benzyloxycarbonyl-L-serine (479 m) dissolved in 2 ml of tetrahydrofuran in a tetrahydrofuran solution of phenylmagnesium bromide (1M, 16 ml) under an argon atmosphere under ice cooling.
g, 2.0 mmol) was added dropwise over 2 minutes. After stirring overnight at room temperature, the mixture was poured into ice water containing 1M hydrochloric acid and extracted with ethyl acetate. The organic layer was washed with water, 5% aqueous sodium hydrogen carbonate solution, water and saturated brine, dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure (2S) -2-
Benzyloxycarbonylamino-3-hydroxy-1
548 mg of phenylpropanone as pale yellow crystals
Obtained (yield 91.5%). The sample recrystallized from ethyl acetate-hexane was white needle-shaped and had m.p. p. 109 ℃,
It was [α] 20 D -5.7 ° (cl, CH 3 OH). 1
It was confirmed by 1 H-NMR spectrum that the compound was (2S) -2-benzyloxycarbonylamino-3-hydroxy-1-phenylpropanone.
【0019】[0019]
【実施例2】実施例1において、N−ベンジルオキシカ
ルボニル−L−セリンに代えてN−ベンジルオキシ−D
−セリンを使用した以外は同様にして(2R)−2−ベ
ンジルオキシカルボニルアミノ−3−ヒドロキシ−1−
フェニルプロパノンを淡黄色結晶として収率85.4%
で得た。 [α]20 D+5.7゜(cl,CH3OH)m.p.10
9℃Example 2 In place of N-benzyloxycarbonyl-L-serine in Example 1, N-benzyloxy-D
-(2R) -2-benzyloxycarbonylamino-3-hydroxy-1-, except that serine was used.
Phenylpropanone as pale yellow crystals, yield 85.4%
Got with. [Α] 20 D + 5.7 ° (cl, CH 3 OH) m.p. p. 10
9 ° C
【0020】[0020]
【実施例3】N−第3ブトキシカルボニル−L−セリン
から実施例1と同様にして、(2S)−2−ジメチルエ
トキシカルボニルアミノ−3−ヒドロキシ−1−フェニ
ルプロパノンを無色のオイルとして収率79.6%で得
た。 [α]20 D−24.4゜(cl,CH3OH)1 H−NMRスペクトルにより生成物を確認した。Example 3 (2S) -2-Dimethylethoxycarbonylamino-3-hydroxy-1-phenylpropanone was collected as a colorless oil from N-tert-butoxycarbonyl-L-serine in the same manner as in Example 1. The yield was 79.6%. The product was confirmed by [α] 20 D −24.4 ° (cl, CH 3 OH) 1 H-NMR spectrum.
【0021】[0021]
【実施例4】N−ベンゼンスルホニル−L−セリンから
実施例1と同様にして(2S)−2−ベンゼンスルホニ
ルアミノ−3−ヒドロキシ−1−フェニルプロパノンを
白色結晶として収率65.9%で得た。 [α]20 D+51.4゜(cl,CH3OH)1 H−NMRスペクトルにより生成物を確認した。Example 4 (2S) -2-benzenesulfonylamino-3-hydroxy-1-phenylpropanone was obtained as white crystals from N-benzenesulfonyl-L-serine in the same manner as in Example 1 in a yield of 65.9%. Got with. The product was confirmed by [α] 20 D + 51.4 ° (cl, CH 3 OH) 1 H-NMR spectrum.
【0022】[0022]
【実施例5】フェニルマグネシウムブロミドのテトラヒ
ドロフラン溶液(1M,9ml)に、アルゴン雰囲気
中、氷冷下にて2mlのテトラヒドロフランに溶解した
N−ベンジルオキシカルボニル−L−セリン(239m
g,1.0ミリモル)を2分間で滴下し、続いて水素化
ホウ素ナトリウム(76mg,2.0ミリモル)を加
え、室温にて一晩攪伴した。1Mの塩酸を含む氷水中に
投入し、酢酸エチルにて抽出した。有機層を水、5%炭
酸水素ナトリウム水溶液、水、飽和食塩水にて洗浄後、
無水硫酸ナトリウム上で乾燥し、溶媒を減圧留去して2
−ベンジルオキシカルボニルアミノ−1−フェニル−
1,3−プロパンジオールの粗生成物を無色のオイルと
して得た。シリカゲルカラムクロマトグラフィー(塩化
メチレンーメタノール)により精製し、(2S)−2−
ベンジルオキシカルボニルアミノ−1−フェニル−1,
3−プロパンジオール(トレオ:エリトロ=1:1)を
収率60%で得た。1H−NMRスペクトルにより生成
物の確認をした。Example 5 N-benzyloxycarbonyl-L-serine (239 m) dissolved in 2 ml of tetrahydrofuran in a tetrahydrofuran solution of phenylmagnesium bromide (1M, 9 ml) under ice cooling in an argon atmosphere.
g, 1.0 mmol) was added dropwise over 2 minutes, sodium borohydride (76 mg, 2.0 mmol) was then added, and the mixture was stirred overnight at room temperature. The mixture was poured into ice water containing 1M hydrochloric acid and extracted with ethyl acetate. The organic layer was washed with water, 5% aqueous sodium hydrogen carbonate solution, water, and saturated saline,
Dry over anhydrous sodium sulfate and evaporate the solvent under reduced pressure to 2
-Benzyloxycarbonylamino-1-phenyl-
The crude product of 1,3-propanediol was obtained as a colorless oil. Purified by silica gel column chromatography (methylene chloride-methanol), (2S) -2-
Benzyloxycarbonylamino-1-phenyl-1,
3-Propanediol (threo: erythro = 1: 1) was obtained with a yield of 60%. The product was confirmed by 1 H-NMR spectrum.
【0023】[0023]
【実施例6】実施例1により得た(2S)−2−ベンジ
ルオキシカルボニルアミノ−3−ヒドロキシー1ーフェ
ニルプロパノン(400mg)をエタノール(10m
l)に溶解し氷冷下にて水素化ホウ素ナトリウム(11
4mg)を加えた。室温にて1晩攪伴した後、5%クエ
ン酸水溶液を加えて反応を止め、酢酸エチルで抽出し
た。有機層を水、飽和食塩水で洗浄し、無水硫酸ナトリ
ウム上で乾燥した。乾燥剤を濾別し溶媒を減圧留去した
ところ(2S)−2−ベンジルオキシカルボニルアミノ
−1−フェニル−1,3−プロパンジオール(トレオ:
エリトロ=1:2)を定量的に得た。1H−NMRスペ
クトルにより生成物の確認をした。Example 6 (2S) -2-benzyloxycarbonylamino-3-hydroxy-1-phenylpropanone (400 mg) obtained in Example 1 was added to ethanol (10 m).
l) and sodium borohydride (11
4 mg) was added. After stirring overnight at room temperature, the reaction was stopped by adding a 5% aqueous citric acid solution, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and saturated brine and dried over anhydrous sodium sulfate. When the desiccant was filtered off and the solvent was distilled off under reduced pressure, (2S) -2-benzyloxycarbonylamino-1-phenyl-1,3-propanediol (threo:
Erythro = 1: 2) was quantitatively obtained. The product was confirmed by 1 H-NMR spectrum.
【0024】[0024]
【実施例7】N−ベンジルオキシカルボニル−L−チロ
シン(2ミリモル)を原料とし、実施例1に準じてフェ
ニルマグネシウムブロミドを反応させた。反応液が懸濁
していたのでテトロヒドロフラン(20ml)を追加し
た。生成液をシリカゲルクロマトグラフィー(塩化メチ
レン−メタノール)により精製し、(2S)−2−ベン
ジルオキシカルボニルアミノ−3−(4−ヒドロキシフ
ェニル)−1−フェニル−1−プロパノンを白色結晶と
して収率9%で得た。 [α]20 D+31.2゜(cl,CH3OH)1 H−NMRスペクトルにより生成物を確認した。Example 7 Using N-benzyloxycarbonyl-L-tyrosine (2 mmol) as a starting material, phenylmagnesium bromide was reacted according to Example 1. Since the reaction solution was suspended, tetrohydrofuran (20 ml) was added. The product solution was purified by silica gel chromatography (methylene chloride-methanol) to give (2S) -2-benzyloxycarbonylamino-3- (4-hydroxyphenyl) -1-phenyl-1-propanone as white crystals in a yield of 9 Earned in%. The product was confirmed by [α] 20 D + 31.2 ° (cl, CH 3 OH) 1 H-NMR spectrum.
【0025】[0025]
【実施例8】N−ベンジルオキシカルボニル−D−セリ
ン(10.0ミリモル)を原料とし、実施例1に準じて
n−ヘキシルマグネシウムブロミド(1M,60ml)
を反応させた。その結果、(2R)−2−ベンジルオキ
シカルボニルアミノ−1−ヒドロキシ−3−ノナノンを
無色のオイルとして収率65%で得た。1H−NMRス
ペクトルにより生成物を確認した。Example 8 Using N-benzyloxycarbonyl-D-serine (10.0 mmol) as a starting material, and following the procedure of Example 1, n-hexyl magnesium bromide (1M, 60 ml).
Was reacted. As a result, (2R) -2-benzyloxycarbonylamino-1-hydroxy-3-nonanone was obtained as a colorless oil in a yield of 65%. The product was confirmed by 1 H-NMR spectrum.
【0026】[0026]
【実施例9】実施例1で得た(2S)−2−ベンジルオ
キシカルボニルアミノ−3−ヒドロキシ−1−フェニル
プロパノンのテトラヒドロフラン溶液(2mmol,1
2ml)に、アルゴン雰囲気中、−78℃にてK−セレ
クトリドのテトラヒドロフラン溶液(1M,8ml)を
10分間で滴下した。そのまま2時間攪伴した後、室温
で1時間攪伴した。1Mの塩酸を加えて反応を止め、酢
酸エチルで抽出した。有機層を水、飽和食塩水で洗浄
し、無水硫酸ナトリウム上で乾燥した。乾燥剤を濾別
し、溶媒を減圧留去して2−ベンジルオキシカルボニル
アミノ−1−フェニル−1,3−プロパンジオールを白
色結晶として収率82%、(1R,2S)−2−ベンジ
ルオキシカルボニルアミノ−1−フェニル−1,3−プ
ロパンジオールをジアステレオマー過剰率90%以上で
得た。1H−NMRスペクトルにより生成物を確認し
た。Example 9 A solution of (2S) -2-benzyloxycarbonylamino-3-hydroxy-1-phenylpropanone obtained in Example 1 in tetrahydrofuran (2 mmol, 1
2 ml) was added dropwise a tetrahydrofuran solution of K-selectride (1M, 8 ml) at −78 ° C. for 10 minutes in an argon atmosphere. The mixture was stirred as it was for 2 hours and then at room temperature for 1 hour. The reaction was stopped by adding 1 M hydrochloric acid, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and saturated brine and dried over anhydrous sodium sulfate. The desiccant was filtered off and the solvent was distilled off under reduced pressure to give 2-benzyloxycarbonylamino-1-phenyl-1,3-propanediol as white crystals in a yield of 82%, (1R, 2S) -2-benzyloxy. Carbonylamino-1-phenyl-1,3-propanediol was obtained with a diastereomeric excess of 90% or more. The product was confirmed by 1 H-NMR spectrum.
【0027】[0027]
【実施例10】(2S)−2−ベンジルオキシカルボニ
ルアミノ−3−ヒドロキシ−1−フェニルプロパノン
(2mmol)を原料とし、実施例10に準じ−78℃
にてジイソブチルアルミニウムハイドライドのn−ヘキ
サン溶液(1M,8ml)を反応させた。その結果、2
−ベンシルオキシカルボニルアミノ−1−フェニル−
1,3−プロパンジオールを白色結晶として反応収率8
0%、(1S,2S)−2−ベンジルオキシカルボニル
アミノ−1−フェニル−1,3−プロパンジオールをジ
アステレオマー過剰率90%以上で得た。1H−NMR
スペクトルにより生成物を確認した。[Example 10] (2S) -2-Benzyloxycarbonylamino-3-hydroxy-1-phenylpropanone (2 mmol) was used as a raw material, and according to Example 10, -78 ° C.
Was reacted with an n-hexane solution of diisobutylaluminum hydride (1M, 8 ml). As a result, 2
-Benzyloxycarbonylamino-1-phenyl-
Reaction yield of 1,3-propanediol as white crystals 8
0% of (1S, 2S) -2-benzyloxycarbonylamino-1-phenyl-1,3-propanediol was obtained with a diastereomeric excess of 90% or more. 1 H-NMR
The product was confirmed by spectrum.
【0028】[0028]
【発明の効果】本発明方法によれば、穏和な条件でα−
アミノ酸誘導体に過剰量のグリニヤール試薬を直接作用
させるという極めて簡単な工程で、光学活性アミノケト
ンを生成することができ、更に、このアミノケトンを還
元して光学活性アミノアルコールを生成する際、還元剤
の種類、溶媒の種類、反応条件等を適宜選択することに
より立体選択的にアミノアルコールを取得することがで
きる。本発明方法は、医薬、農薬の合成中間体として或
いは光学分割剤として有用な光学活性アミノケトン及び
光学活性アミノアルコールの効果的製造方法である。According to the method of the present invention, α-
An optically active aminoketone can be produced by a very simple process of directly reacting an excess amount of Grignard reagent with an amino acid derivative, and further, when the aminoketone is reduced to produce an optically active aminoalcohol, the kind of the reducing agent is used. The amino alcohol can be stereoselectively obtained by appropriately selecting the type of solvent, reaction conditions and the like. INDUSTRIAL APPLICABILITY The method of the present invention is an effective method for producing an optically active aminoketone and an optically active amino alcohol, which are useful as synthetic intermediates for medicines and agricultural chemicals or as optical resolving agents.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 // C07M 7:00 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 6 Identification number Office reference number FI technical display area // C07M 7:00
Claims (6)
R2は置換基を有していてもよい炭素数1から8のアル
キル、アリール、アラルキル基を示し、また、R1とR2
は連結して−(CH2)3−又は−CH2−CH(OH)
−CH2−を示す。C*は不斉炭素原子を示す。)で示さ
れるα−アミノ酸誘導体に、一般式(2) R3MgX ・・・・(2) (式中、Xはハロゲン原子であり、R3は炭素数6から
20の置換基を有していても良い炭化水素基である。)
で示されるグリニヤール試薬を、該α−アミノ酸誘導体
に対し少なくとも5モル使用し、且つ、還流温度以下で
反応させることを特徴とする一般式(3) R1−NH−C*H(R2)−COR3 ・・・・(3) (式中、R1、R2、R3及びC*は前記と同義である。)
で示される光学活性アミノケトンの製造方法。1. General formula (1) R 1 —NH—C * H (R 2 ) —COOH (1) (wherein R 1 represents an alkyl group or an amino-protecting group,
R 2 represents an optionally substituted alkyl, aryl or aralkyl group having 1 to 8 carbon atoms, and R 1 and R 2
They are linked - (CH 2) 3 - or -CH 2 -CH (OH)
-CH 2 - shows the. C * represents an asymmetric carbon atom. ) In the α-amino acid derivative represented by the general formula (2) R 3 MgX ··· (2) (In the formula, X is a halogen atom, and R 3 has a substituent having 6 to 20 carbon atoms. It is a hydrocarbon group which may be present.)
The Grignard reagent represented by the formula (3) R 1 —NH—C * H (R 2 ) is used in an amount of at least 5 mol with respect to the α-amino acid derivative, and is reacted at a reflux temperature or lower. -COR 3 ... (3) (In the formula, R 1 , R 2 , R 3 and C * are as defined above.)
A method for producing an optically active aminoketone represented by:
酸誘導体に、一般式(2)で示されるグリニヤール試薬
を該α−アミノ酸誘導体に対し少なくとも5モル使用
し、還流温度以下で反応させて一般式(3)で示される
光学活性アミノケトンを生成し、次いで該アミノケトン
を還元することを特徴とする一般式(4) R1−NH−C*H(R2)−C*H(OH)R3 ・・・・(4) (式中、R1、R2、R3及びC*は前記と同義である。)
で示される光学活性アミノアルコールの製造方法。2. The α-amino acid derivative represented by the general formula (1) is used at least 5 mol of the Grignard reagent represented by the general formula (2) with respect to the α-amino acid derivative, and reacted at a reflux temperature or lower. To produce an optically active aminoketone represented by the general formula (3), and then to reduce the aminoketone, the general formula (4) R 1 —NH—C * H (R 2 ) —C * H (OH ) R 3 ... (4) (In the formula, R 1 , R 2 , R 3 and C * are as defined above.)
And a method for producing an optically active amino alcohol.
酸誘導体に、一般式(2)で示されるグリニヤール試薬
を該α−アミノ酸誘導体に対し少なくとも5モル使用
し、且つ、還流温度以下で還元剤の存在下反応させるこ
とを特徴とする一般式(4) R1−NH−C*H(R2)−C*H(OH)R3 ・・・・(4) (式中、R1、R2、R3及びC*は前記と同義である。)
で示される光学活性アミノアルコールの製造方法。3. A Grignard reagent represented by the general formula (2) is used in the α-amino acid derivative represented by the general formula (1) in an amount of at least 5 mol with respect to the α-amino acid derivative, and at a reflux temperature or lower. General formula (4) characterized by reacting in the presence of a reducing agent R 1 —NH—C * H (R 2 ) —C * H (OH) R 3 ... (4) (wherein R 1 , R 2 , R 3 and C * are as defined above.)
And a method for producing an optically active amino alcohol.
オキシカルボニル基、t−ブチルオキシカルボニル基、
フルオレニルメチルオキシカルボニル基、ベンゼンスル
ホニル基またはフタロイル基から選ばれるアミノ保護基
であるα−アミノ酸誘導体であることを特徴とする請求
項1、2または3のいずれかに記載の製造方法。4. In the general formula (1), R 1 is a benzyloxycarbonyl group, a t-butyloxycarbonyl group,
The method according to claim 1, wherein the α-amino acid derivative is an amino-protecting group selected from a fluorenylmethyloxycarbonyl group, a benzenesulfonyl group and a phthaloyl group.
ケトンを環状エーテル溶媒中、水素化ホウ素系還元剤の
存在下還元し、一般式(4)で示される光学活性アミノ
アルコールのトレオ体を選択的に製造することを特徴と
する請求項2に記載の製造方法。5. An optically active aminoketone represented by the general formula (3) is reduced in a cyclic ether solvent in the presence of a borohydride reducing agent to give a threo form of the optically active aminoalcohol represented by the general formula (4). The manufacturing method according to claim 2, wherein the manufacturing is performed selectively.
ケトンをアルコール溶媒中、水素化ホウ素系還元剤の存
在下還元し、一般式(4)で示される光学活性アミノア
ルコールのエリトロ体を選択的に製造することを特徴と
する請求項2に記載の製造方法。6. An erythro body of an optically active aminoalcohol represented by the general formula (4) is selected by reducing an optically active aminoketone represented by the general formula (3) in an alcohol solvent in the presence of a borohydride reducing agent. The manufacturing method according to claim 2, wherein the manufacturing method is carried out.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21525594A JP3856850B2 (en) | 1994-08-18 | 1994-08-18 | Process for producing optically active aminoketone and aminoalcohol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21525594A JP3856850B2 (en) | 1994-08-18 | 1994-08-18 | Process for producing optically active aminoketone and aminoalcohol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0859576A true JPH0859576A (en) | 1996-03-05 |
| JP3856850B2 JP3856850B2 (en) | 2006-12-13 |
Family
ID=16669292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21525594A Expired - Lifetime JP3856850B2 (en) | 1994-08-18 | 1994-08-18 | Process for producing optically active aminoketone and aminoalcohol |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3856850B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4728548B2 (en) * | 1999-09-07 | 2011-07-20 | 三菱レイヨン株式会社 | Method for producing optically active amino alcohol |
| US8022082B2 (en) | 2002-04-09 | 2011-09-20 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Method for the administration of an anticholinergic by inhalation |
| JP2013529597A (en) * | 2010-06-11 | 2013-07-22 | サノフイ | Synthetic method of ferroquine by intensive reductive amination |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49202A (en) * | 1972-04-18 | 1974-01-05 | ||
| JPS5029535A (en) * | 1973-06-26 | 1975-03-25 | ||
| JPS62209047A (en) * | 1986-03-11 | 1987-09-14 | Nippon Chemiphar Co Ltd | Production of optically active beta-aminoalcohol |
| JPH023615A (en) * | 1988-03-03 | 1990-01-09 | Gruppo Lepetit Spa | Method for manufacturing a tertiary methanol containing an amino acid residue |
-
1994
- 1994-08-18 JP JP21525594A patent/JP3856850B2/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49202A (en) * | 1972-04-18 | 1974-01-05 | ||
| JPS5029535A (en) * | 1973-06-26 | 1975-03-25 | ||
| JPS62209047A (en) * | 1986-03-11 | 1987-09-14 | Nippon Chemiphar Co Ltd | Production of optically active beta-aminoalcohol |
| JPH023615A (en) * | 1988-03-03 | 1990-01-09 | Gruppo Lepetit Spa | Method for manufacturing a tertiary methanol containing an amino acid residue |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4728548B2 (en) * | 1999-09-07 | 2011-07-20 | 三菱レイヨン株式会社 | Method for producing optically active amino alcohol |
| US8022082B2 (en) | 2002-04-09 | 2011-09-20 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Method for the administration of an anticholinergic by inhalation |
| JP2013529597A (en) * | 2010-06-11 | 2013-07-22 | サノフイ | Synthetic method of ferroquine by intensive reductive amination |
| JP2016145214A (en) * | 2010-06-11 | 2016-08-12 | サノフイ | Method of synthesis of ferroquine by convergent reductive amination |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3856850B2 (en) | 2006-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5618966A (en) | Method forming protease inhibitor synthetic intermediates | |
| JPS6323834A (en) | Malonic acid derivative | |
| JPWO1996023756A1 (en) | Method for producing α-haloketones, α-halohydrins and epoxides | |
| JP3856850B2 (en) | Process for producing optically active aminoketone and aminoalcohol | |
| JP5207226B2 (en) | Proteasome inhibitors containing tamoxifen analogs as active ingredients | |
| EP0612716B1 (en) | Process for the preparation of an optically pure aminoalcohol | |
| JP2006249095A (en) | Amino acid-derived diaminopropanol | |
| CA2184500A1 (en) | Synthesis of compounds with predetermined chirality | |
| JP4143787B2 (en) | Method for producing α-aminohalomethyl ketone derivative | |
| JPH0228144A (en) | Production of stereospecific intermediate useful for synthesis of peptide derivative | |
| US5939554A (en) | Diarylaminopropanediol and diarylmethyl-oxazolidinone compounds | |
| EP2084125A1 (en) | Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy | |
| JP3469156B2 (en) | Asymmetric Michael Addition Reaction Method of Chiral Metal Catalyst and Thiol | |
| JPH078855B2 (en) | Sulfonium compound | |
| JP3866323B2 (en) | Novel N-benzylbenzamide derivatives | |
| JP2825608B2 (en) | Optically active threo-3-amino-2-hydroxypentanoic acid and process for producing the same | |
| HU207711B (en) | Process for producing glutaric acid derivatives | |
| JP3832919B2 (en) | Method for producing optically active cyanohydrin | |
| PT101847B (en) | SUBSTITUTED PEPTIDE DERIVED FROM LYSINE AND PROLINE | |
| JPH08259519A (en) | Process for producing α-aminoglycol and intermediate thereof | |
| JP3740783B2 (en) | Process for producing 4- (2-alkenyl) -2,5-oxazolidinediones | |
| JP4258227B2 (en) | Process for the preparation of phenylalanine derivatives and synthetic intermediates thereof | |
| JP3845884B2 (en) | Process for producing N- [1- (2,4-dichlorophenyl) ethyl] -2-cyano-3,3-dimethylbutanamide | |
| EP0837843B1 (en) | Method for preparing enantiomeric forms of amino alkylaminophenyl propanoic acid | |
| JP4157175B2 (en) | Method for producing 2'-pyrrolidinepropanoic acid derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050420 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050531 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050729 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20050729 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060509 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060607 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060912 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060913 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090922 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100922 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110922 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110922 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120922 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130922 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |